{"nct_id":"NCT01907087","title":"A Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Efficacy of Intracerebroventricular BMN 190 in Patients With Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2) Disease","status":"COMPLETED","status_verified_date":"2019-03","start_date":"2013-09","start_date_type":null,"primary_completion_date":"2015-11","primary_completion_date_type":"ACTUAL","completion_date":"2015-11","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["BMRN"]}